Jim Cramer Recommends Johnson & Johnson Stock: A Deep Dive

Investment Recommendation: Johnson & Johnson

• 💡 Jim Cramer recommends buying shares of Johnson & Johnson (J&J), highlighting a recent sensational interview with Joe Wal and Squall.
• 🎯 J&J is noted for its significant domestic manufacturing, which Cramer suggests will mitigate the impact of potential industry downturns.
• 💰 The company has raised forecasts for big pharma indications in the middle years, indicating strong future growth potential.

Key Products and Growth Areas

• 🚀 Bravado, initially a small product for depression, has become a very significant revenue driver for J&J.
• 📈 J&J is also developing very good treatments for Crohn's disease.
• 💊 The company is recognized as a premier developer of fantastic drugs, with a strong pipeline.

Financials and Legal Considerations

• 📊 J&J is trading at 14 times earnings, which Cramer views as an attractive valuation.
• ⚖️ Cramer believes J&J's talc problems are now behind it, with the company having only lost one case so far.

Policy and Manufacturing Incentives

• 🗣️ The discussion touches on the idea that tax policy, rather than tariffs, is the best way to incentivize pharmaceutical and medical device manufacturing.
• 🧠 Cramer praises Joe Wal and Squall for his intelligence and understanding of complex issues, advocating for leveraging the expertise of great citizens to inform policy.